Reprogram Biosciences
Latest round
- Seed
Last raised
- Mar 2026
Total raised
- $5M
Investors
- 3
About Reprogram Biosciences
Reprogram Biosciences Inc. specializes in advanced cancer therapies through reprogramming cancer cells. Founded in 2025, By Co-founders Rustam Esanov(CEO) and Eziz Kuliyev (COO). the company is headquartered in San Carlos, US. Reprogram Biosciences specializes in innovative cancer treatment solutions through its core product offerings, which focus on reprogramming cancer cells into immune-like cells within patients. The company employs a novel therapeutic gene cocktail delivered via a cutting-edge lipid nanoparticle system, enabling precision targeting of solid tumors. This transformative immunotherapy approach empowers the body’s immune system to combat cancer more effectively and affordably, directly addressing the critical need for advanced treatment modalities in oncology. Reprogram Biosciences aims to provide these services primarily to healthcare institutions and oncology clinics across North America and Europe, targeting a wide range of solid tumors.Reprogram Biosciences generates revenue through direct partnerships with healthcare providers, oncology clinics, and research institutions that adopt its innovative therapeutic solutions. The company's transactions are structured around the provision of its flagship gene reprogramming therapies, which are offered as ready-to-use treatments for solid tumors. Clients may engage in agreements that involve purchasing treatment packages tailored to specific cancer types, facilitating streamlined access to cutting-edge immunotherapies. The pricing structure reflects the advanced nature of the therapies, encompassing costs associated with the proprietary gene reprogramming technologies and lipid nanoparticle delivery systems. Overall, the company's revenue model emphasizes collaboration with healthcare entities to facilitate the adoption and distribution of its transformative cancer treatments. In March 2026, Reprogram Biosciences Inc. The company is focusing on developing new treatment products aimed at enhancing its therapeutic offerings in oncology. Plans include expanding its market reach into regions across Europe and North America by the end of 2027.
Who invested in Reprogram Biosciences
3 investors across 1 round
See all investors in Reprogram Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 16, 2026
Amount
$5M
Investors
Questions about Reprogram Biosciences
Who invested in Reprogram Biosciences?
Reprogram Biosciences has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Reprogram Biosciences raised?
Reprogram Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Reprogram Biosciences last raise money?
Reprogram Biosciences's most recent round on record is a Seed, in Mar 2026.
What does Reprogram Biosciences do?
Reprogram Biosciences is a healthcare specialists company.
Where is Reprogram Biosciences headquartered?
Reprogram Biosciences is headquartered in San Carlos, US.
Which VCs invest in companies like Reprogram Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Reprogram Biosciences's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Seed
Raising like Reprogram Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.